Skip to main content
. 2022 Aug 17;13:967380. doi: 10.3389/fendo.2022.967380

Table 2.

Components of Metabolic syndrome among all participants with and without thyroid nodules (N = 2,784).

Variables All Participants Thyroid nodule (s) absent (n = 1,851) Thyroid nodule (s) present (n = 933) χ2 P
Hypertension 29.821 0.000
 Yes 922 (33.1%) 549 (29.7%) 373 (40.0%)
 No 1862 (66.9%) 1302 (70.3%) 560 (60.0%)
Central obesity 25.857 0.000
 Yes 280 (10.1%) 224 (12.1%) 180 (19.3%)
 No 2504 (89.9%) 1627 (87.9%) 753 (80.7%)
Level of FBG 11.284 0.001
 Hyperglycemia (FBG ≥6.1 mmol/L) 111 (4.0%) 161 (8.7%) 119 (12.8%)
 Normal 2673 (96.0%) 1690 (91.3%) 814 (87.2%)
Level of TG 32.854 0.000
 High TG (≥1.70 mmol/L) 606 (21.8%) 344 (18.6%) 262 (28.1%)
 Normal 2178 (78.2%) 1507 (81.4%) 671 (71.9%)
Level of HDL -C 0.061 0.805
 Low HDL -C (<1.04 mmol/L) 101 (3.6%) 66 (3.6%) 35 (3.8%)
 Normal 2683 (96.4%) 1785 (96.4%) 898 (96.2%)

p values were from the chi-square test for categorical variables; Categorical variables are presented as number (percentage); Hypertension: blood pressure ≥ 130/85 mm Hg and/or diagnosed hypertension; Abdominal obesity: female waist circumference ≥ 85 cm; Hyperglycemia (FBG ≥ 6.1 mmol/L). FBG, fasting blood glucose; TG, triglyceride; HDL -C, High-density lipoprotein cholesterol; LDL -C, Low-density lipoprotein cholesterol.Bold means, P values are statistically significant.